EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 4.0

Combined Oral Anticoagulant and Antiplatelet for Atrial Fibrillation and Cerebral Atherosclerosis: A Meta-Analysis

Hyungwoo Lee, JoonNyung Heo, Jae Wook Jung, Hyo Suk Nam, Young Dae Kim

Journal of Stroke · 31.05.2026 · 28 (2) · 303-311

DOI: 10.5853/jos.2025.04609 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Stroke, erschienen am 31.05.2026. Verfasst von Hyungwoo Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Yonsei University College of Medicine, Seoul, Korea. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Patients with ischemic stroke with both atrial fibrillation (AF) and large artery atherosclerosis (LAA) represent therapeutic challenges, and the optimal antithrombotic regimen remains uncertain. We conducted a meta-analysis comparing oral anticoagulant (OAC) monotherapy with OAC plus antiplatelet therapy in this population.Methods PubMed and EMBASE were searched through June 30, 2025, for studies enrolling patients with ischemic stroke and evidence of both AF and LAA. Outcomes included recurrent ischemic stroke, major bleeding, all-cause mortality, and a composite outcome. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using the Peto method, with random-effects sensitivity analyses, stratified by short-term (

Schlagwörter

Stichwörter der Autor:innen

AnticoagulantAntiplateletAtherosclerosisAtrial fibrillationStroke

Autor:innen und Institutionen

  • Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Integrative Research Center for Cerebrovascular and Cardiovascular Diseases, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Neurology, Yonsei University College of Medicine, Seoul, Korea. neuro05@yuhs.ac.
  • Integrative Research Center for Cerebrovascular and Cardiovascular Diseases, Yonsei University College of Medicine, Seoul, Korea. neuro05@yuhs.ac.

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare

Zitieren

APA

Lee, H., Heo, J., Jung, J. W., Nam, H. S., & Kim, Y. D. (2026). Combined Oral Anticoagulant and Antiplatelet for Atrial Fibrillation and Cerebral Atherosclerosis: A Meta-Analysis. Journal of Stroke, 28(2), 303-311. https://doi.org/10.5853/jos.2025.04609

Vancouver

Lee H, Heo J, Jung JW, Nam HS, Kim YD. Combined Oral Anticoagulant and Antiplatelet for Atrial Fibrillation and Cerebral Atherosclerosis: A Meta-Analysis. Journal of Stroke. 2026;28(2):303-311. doi:10.5853/jos.2025.04609

BibTeX
@article{Lee2026,
  author = {Lee, Hyungwoo and Heo, JoonNyung and Jung, Jae Wook and Nam, Hyo Suk and Kim, Young Dae},
  title = {Combined Oral Anticoagulant and Antiplatelet for Atrial Fibrillation and Cerebral Atherosclerosis: A Meta-Analysis},
  journal = {Journal of Stroke},
  year = {2026},
  volume = {28},
  number = {2},
  pages = {303--311},
  doi = {10.5853/jos.2025.04609}
}
Kostenlos starten →